Literature DB >> 8556149

Liquid chromatographic-mass spectrometric studies on the enzymatic degradation of beta-endorphin by endothelial cells.

M Brudel1, U Kertscher, D Schröder, M F Melzig, B Mehlis.   

Abstract

An on-line HPLC-mass spectrometric procedure with an electrospray atmospheric pressure ionization (ESI-API) ion source was developed to identify the enzymatic degradation products (peptides) generated by incubation of human beta-endorphin (h beta E) with cultured aortic endothelial cells. The samples from the complex incubation mixture were prepurified and enriched using a small reversed-phase (RP) perfusion precolumn. Flow switching was applied to transfer the peptides from this precolumn to the analytical RP column of 2 or 0.32 mm I.D. and to separate them by gradient elution. The peptides were detected by means of an on-line coupled triple quadrupole mass spectrometer (TSQ 700) with an ESI-API ion source operated in the positive ion mode. This MS system behaves as a concentration sensitive detector at flow-rates from 5 to 150 microliters/min. MS-MS experiments supported the unambiguous assignment of the peptide structures. Thus most of the peptide fractions were identified and the region 16-17-18 (-L-F-K-) of h beta E was found to be primarily attacked by the enzymes of the endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8556149     DOI: 10.1016/0021-9673(95)00564-4

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Beta-endorphin 1-31 biotransformation and cAMP modulation in inflammation.

Authors:  Naghmeh Hajarol Asvadi; Michael Morgan; Herath M Herath; Amitha K Hewavitharana; P Nicholas Shaw; Peter J Cabot
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

Review 2.  Neuroimmune Interaction in the Regulation of Peripheral Opioid-Mediated Analgesia in Inflammation.

Authors:  Susan Hua
Journal:  Front Immunol       Date:  2016-08-02       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.